Positive values indicate a favorable currency impact, while negative values indicate a drag on comprehensive income due to currency depreciation.
Represents the gains or losses resulting from the translation of financial statements of foreign subsidiaries into the r...
Standard for multinational corporations with significant international operations and exposure to multiple currencies.
other_goodwill_foreign_currency_translation_gain_loss| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Corporate | — | — | $0.00 | $0.00 | $0.00 | — | — | — |
| International | -$14.00M | $16.00M | -$83.00M | $0.00 | $75.00M | — | — | — |
| Medical-Surgical Solutions | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| North American Pharmaceutical | — | — | — | — | — | — | $19.00M | — |
| Oncology & Multispecialty | — | — | — | — | — | — | $0.00 | $0.00 |
| Prescription Technology Solutions | — | $0.00 | $0.00 | — | — | $0.00 | $0.00 | $0.00 |
| U.S. Pharmaceutical | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — |
| Total | — | — | — | — | — | — | — | — |
Corporate, International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.